Free Shipping 30-Day Money-Back Guarantee.

The science behind Leap Years

Tested in dogs. Published for all to see. Built for more good years.

Most dog supplements borrow their science from mice or people. Leap Years was put through a randomized, placebo-controlled trial at the NC State College of Veterinary Medicine, and the results were published in a peer-reviewed journal. Here is that science, in plain words.

  • Clinically studied in dogs
  • Peer-reviewed
  • Double-blind
  • Placebo-controlled
Scientific ReportsMay 2024

A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination

Simon KE, Russell K, Mondino A, Yang CC, Case BC, Anderson Z, Whitley C, Griffith E, Gruen ME, Olby NJ

Where
NC State College of Veterinary Medicine
Journal
Scientific Reports 14, 12399 (2024)
DOI
10.1038/s41598-024-63031-w
Read the published study

The short version
in three parts

If you only have a minute, this is the whole page.

What it is

A daily chew with two jobs

An NAD+ precursor that helps cells keep their energy supply. And a senolytic, given two days a month, that supports the body's natural clearing of worn-out cells.

What the study found

Improved cognitive function in 3 months

In the trial, senior dogs on the full dose showed the largest improvement in cognitive function, as rated by their owners. A statistically significant result, published in a peer-reviewed journal.

How it feels day to day

Well tolerated, easy to give

Well tolerated in the trial, with safety checks on par with placebo. A soft, beef-flavored chew most dogs take like a treat, once every morning.

Aging starts
inside the cell

Scientists have mapped the key processes behind aging, called the hallmarks of aging. Leap Years is built around two of them.

Change 1

NAD+, the fuel cells run on

NAD+ is a molecule every cell uses to turn food into energy and to keep itself in good repair. Research shows NAD+ levels fall as the body ages. Supporting NAD+ helps cells keep doing their job.

NAD+ LEVEL Younger Older
Illustration of the pattern described in aging research.
Change 2

Senescent, or "zombie," cells

Some cells stop working but do not clear out. Researchers call them senescent, or "zombie," cells, and they send out signals that disturb the healthy cells around them. Supporting the body's natural clearing of these cells helps the healthy ones thrive.

Younger tissue with normal cells next to older tissue with more senescent cells
Illustration of the pattern described in aging research.
Why both

Clear out what is not working. Refuel what is. Most supplements pick one lever. Leap Years works on both, and it is this exact combination that was tested in the NC State trial.

One month
two chews

Leap Years is a monthly cycle, not a single pill. The schedule below is the same one used in the NC State trial.

Days 1 and 2

The golden chew

LY-D6 · Senolytic + NAD+ precursor

Two days in a row at the start of each month. It supports the body's natural clearing of senescent cells and gives NAD+ a boost.

Days 3 to 31

The brown chew

LY-D2 · NAD+ precursor

Once every morning for the rest of the month. It keeps supporting NAD+ day to day. Then the cycle starts again.

Same schedule as the study. In the trial, dogs got the NAD+ precursor daily and the senolytic on two days in a row each month. Doses were set from earlier safety and dosing studies, and the serving scales with your dog's weight.

How the study
was run

Most dog supplements are never tested in dogs. This one was tested the way medicines are: against a placebo, with nobody knowing who got what.

The trial in numbers

70senior dogs enrolled
3groups, including placebo
6months of follow-up
p = 0.02on the main measure

Which dogs took part

  • 10 years old or older
  • Over 6 kg (about 13 lb)
  • Showing early signs of cognitive aging, rated on a standard veterinary scale
  • Able to walk on their own and interested in treats
PlaceboLook-alike chew, nothing active
Low doseLeap Years, reduced dose
Full doseLeap Years, full dose
Randomized

A computer decided which dog went in which group. That keeps the groups fair.

Placebo-controlled

One group got look-alike chews with nothing active. It is the fair comparison every result is measured against.

Double-blind

Neither owners nor researchers knew which dog got what until the analysis was done.

Peer-reviewed

Independent scientists reviewed the work before the journal published it.

Day 0Starting point
1 monthCheck-in
3 monthsMain measure
6 monthsFollow-up

The result
improved cognitive function

Main result · 3 months

Senior dogs on Leap Years showed improved cognitive function, as assessed by their owners. The full dose delivered the largest improvement.

"We conclude that LY-D6/2 improves owner-assessed cognitive function over a 3-month period and may have broader, but more subtle effects on frailty, activity and happiness as reported by owners."The study authors, Scientific Reports, 2024

p = 0.02 on the main measure

A p-value of 0.02 means a result this strong would show up by chance only about 2 times in 100. That clears the bar scientists use to call a result statistically significant.

What owners rated

The CCDR, a 13-question rating scale used by veterinary researchers to track cognitive function in senior dogs. It covers everyday behavior, like recognizing familiar people and finding the way around the house.

Why owners do the rating

Owners see their dog every day, at home, in real life. Not for twenty minutes in an exam room.

That is why veterinary researchers rely on validated owner scales like the CCDR to measure cognitive function in senior dogs. It captures the dog you actually live with.

What owners noticed

The questions owners answered are about everyday life: does the dog recognize familiar people, find its way around the house, and move through its day without getting stuck or lost.

That is what improved most in the full-dose group. Not a lab score. The dog you live with.

In Stock: Delivered by from U.S.A.

Start My Dog's First Month

30 Day Money Back Guarantee

  • Free Shipping
  • Cancel Anytime
Or read the full study

Gentle on your dog
made to a higher standard

Tolerability

Well tolerated

In the NC State trial, dogs on Leap Years did as well on safety checks and bloodwork as dogs on placebo. The researchers described the chews as well tolerated.

A soft, beef-flavored chew that most dogs take like a treat.

Quality

Made in the USA

Active ingredients and soft chews are made in FDA-registered, audited facilities, under the same Current Good Manufacturing Practice (cGMP) standard set by the FDA for pharmaceutical products.

Every batch is tested and inspected before release to confirm it meets specification and is free of contaminants. An adverse event reporting system flags any safety or quality concern immediately.

What this means
for your dog

The study measured its main result at 90 days. Here is what the first three months look like.

Leap Years jar with golden and brown chews Leap Years jar with golden and brown chews
Month 1

Start the routine.

Golden chews on days 1 and 2, then one brown chew every morning. It takes seconds, and most dogs take it like a treat. Jot down a few notes on how your dog is today.

Month 2

Build momentum.

A new golden chew reset starts the month. Keep the routine going every morning. Consistency is what the study measured.

Month 3

The 90-day mark.

This is when the NC State trial measured its main result. Look back at your month 1 notes and see what has changed.

Senior dog working on a puzzle toy

What to watch for

  • Does your dog respond the first time you call?
  • Do they recognize familiar people and dogs?
  • Do they find their way around the house easily?
  • Do they stay interested in toys, walks and you?

These are the everyday signs the study tracked.

In Stock: Delivered by from U.S.A.

Start My Dog's First Month

30 Day Money Back Guarantee

  • Free Shipping
  • Cancel Anytime

Built on
published aging research

The biology behind Leap Years. These papers explain the biology behind Leap Years. The NC State trial is where the formula was put to the test in dogs.

Understanding aging

Hallmarks of aging: an expanding universe

A review of 12 connected processes behind aging, including cellular senescence and changes in how cells use energy.

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Cell, 2023.

Read the paper
NAD+

Therapeutic potential of NAD-boosting molecules: the in vivo evidence

A review of NAD+ in metabolism and cell health, how NAD+ levels change with age, and what boosting it has done in animal studies.

Rajman L, Chwalek K, Sinclair DA. Cell Metabolism, 2018.

Read the paper
Senescent cells

The metabolic roots of senescence

A review of senescent cells, the signals they send out, and how energy problems inside cells relate to them.

Wiley CD, Campisi J. Nature Metabolism, 2021.

Read the paper
Dogs and aging

Lifespan of companion dogs seen in three primary care veterinary clinics in the United States

A study of how long pet dogs live. Large dogs live shorter lives on average than small dogs, independent of breed ancestry.

Urfer SR, Kaeberlein M, Promislow DEL, Creevy KE. Canine Medicine and Genetics, 2020.

Read the paper

For veterinarians
the details that matter

Design

At a glance

  1. Randomized, double-blind, placebo-controlled, three arms: placebo, low dose, full dose.
  2. 70 client-owned dogs aged 10 and older with mild to moderate cognitive impairment, enrolled at NC State College of Veterinary Medicine.
  3. Primary endpoint: change in owner-completed CCDR score at 3 months (p = 0.02 across groups, largest improvement at full dose).
  4. Adverse events and bloodwork changes distributed similarly across all groups, including placebo.
  5. Published in Scientific Reports, a peer-reviewed Nature Portfolio journal, in 2024.
Citation

The paper

Simon KE, Russell K, Mondino A, Yang CC, Case BC, Anderson Z, Whitley C, Griffith E, Gruen ME, Olby NJ. A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination. Scientific Reports. 2024;14:12399. DOI: 10.1038/s41598-024-63031-w

The full paper, including all secondary measures, is open access. We are happy to send it to your clinic.

Request vet information

Questions
we get about the science

How soon will I see a difference?

Some pet parents notice changes within the first weeks. The trial measured its main result at 90 days, so give it the full three months and compare with your notes from month 1.

Will it work for my dog?
Is it safe?
When should I start?
Why is the senolytic only given two days a month?

More good years together.

A two-part daily chew, clinically studied in dogs and published in a peer-reviewed journal. Start your dog's first 90 days today.

In Stock: Delivered by from U.S.A.

Start My Dog's First Month

30 Day Money Back Guarantee

  • Free Shipping
  • Cancel Anytime
Or read the full study